# ARCALYST

- **Website:** <https://arcalyst.com>
- **Primary alias:** `arcalyst.com`

## Description

ARCALYST® (rilonacept) is a significant innovation in the treatment of recurrent pericarditis, recognized as the first and only therapy approved by the FDA for patients aged 12 and older. Developed by Kiniksa Pharmaceuticals, ARCALYST serves as an interleukin-1 blocker that not only addresses recurrent pericarditis but also manages associated conditions such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Deficiency of Interleukin (IL-1) Receptor Antagonist (DIRA). 

The therapy is designed to reduce flares, provide symptom relief, and promote long-term prevention of recurrence, thereby enhancing the quality of life for individuals affected by these conditions. The brand offers comprehensive support through its Kiniksa OneConnect™ program, which includes starter kits, treatment support, and financial assistance for patients. With a commitment to patient advocacy and education, ARCALYST aims to empower users to take control of their health, ensuring they have access to vital resources and community support.

## Industries

- ⛑ Health
- ⛑ Biotechnology and Pharmaceuticals _(under Health)_

## Logos & icons

- logo _(primary)_ — PNG — [download](https://cdn.brandfetch.io/idQrwATaS9/w/310/h/100/theme/dark/logo.png?c=1bxid64Mup7aczewSAYMX&t=1789858365584)

## Colors

| Name | Hex | Theme |
| --- | --- | --- |
| Smalt Blue | #54768f | accent |
| Chathams Blue | #13426b | dark |
| White | #ffffff | light |

## Fonts

- var(--ssa-font-stacks-roboto) — asset _(custom)_
- var(--ssa-font-stacks-roboto) — asset _(custom)_

---

_Source: <https://brandfetch.com/arcalyst.com>_
_See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._